pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›drugs
  3. ›Pregabalin
drug
save

pregabalin ER

Marketedupdated 6mo ago
by Novadoz Pharmaceuticals LLC
Approved
community read0 votes

🐶 often sniffed alongside

top 8
  • tagApproval58 co-mentions · 29 sources
  • drugLyrica29 co-mentions · 29 sources
  • drugpregabalin CR29 co-mentions · 29 sources
  • tagSmall Molecule29 co-mentions · 29 sources
  • drugPREGABALIN29 co-mentions · 29 sources
  • drugpregabalin SR29 co-mentions · 29 sources
  • companyLupin Ltd3 co-mentions · 3 sources
  • companyStrides Pharma Inc3 co-mentions · 3 sources

all catalysts(0)

nothing on the calendar yet

Trials studying pregabalin ER

  • phase1Pharmacokinetics of Y-4 Tablets With Pregabalin Capsules and Riluzole Tablets in U.S. Healthy Participantsnot yet recruitingn=11
  • phase2Evaluation of Efficacy and Safety of VX-993 for Pain Associated With Diabetic Peripheral Neuropathyrecruitingn=300
  • phase1A Study of HRS-2129 in Patients With Diabetic Peripheral Neuropathic Painrecruitingn=168
  • phase2Y-4 to Treat the Postherpetic Neuralgiarecruitingn=160
  • phase3Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathyrecruitingn=1,100
  • —A Study Following Women in Menopause Treated With a Non-hormonal Therapy for Hot Flashes and Night Sweatsactive not recruitingn=999
  • phase2Evaluation of Efficacy and Safety of VX-548 for Painful Diabetic Peripheral Neuropathy (DPN)completedn=194
  • EP1Pharmacodynamic Study of 300mg Pregabalin vs Placebo in Healthy Male Adultscompletedn=20

News(1)

  • Biotech’s peptide shows promise as ‘bait molecule’ to treat neuropathic pain in mice
    While psychedelic drugs may be capturing all the attention when it comes to finding fresh ways to treat neuropathic pain, research with mice has suggested a peptide approach may also be effective.
    fiercebiotech · 1mo ago
brand
Pregabalin
generic
pregabalin
indication
Diabetic Neuropathic Pain
phase
marketed
Data sources
ClinicalTrials.gov
last refreshed 6h ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?